Seed, Series A
$200K – $2.5M
6+ companies
1 partner
Investment Thesis
Focuses on startups building innovative pharmacy supply chain solutions and healthcare software platforms serving emerging markets.
Meet the Team
Anil Gupta
Partner
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (6)
Other
RxGlobal Tech
Arvinas
"Discovered via perplexity (medium confidence)"
Biopharmaceutical developing small molecule therapeutics for protein degradation in cancer.
Audentes (now Astellas Gene Therapies)
"Discovered via perplexity (medium confidence)"
Biotech for viral-based gene therapy in rare diseases.
Deverra
"Discovered via perplexity (medium confidence)"
Clinical-stage off-the-shelf cellular immunotherapies for cancer and infections.
Dianthus Therapeutics
"Discovered via perplexity (medium confidence)"
Monoclonal antibodies for autoimmune diseases.
Neurogastrx
"Discovered via perplexity (medium confidence)"
Therapies for gastrointestinal disorders.
Browse More Investors
Frequently Asked Questions
See if Pharma Tech Ventures is a match for your startup
Upload your pitch deck to see how well you match with Pharma Tech Ventures and 200+ other VC firms.